Disease-modifying antirheumatic drugs (DMARDs) for rheumatoid arthritis after failure of biologic or targeted synthetic therapy: a systematic review and network meta-analysis.

Thomas J, Kamso MM, Whittle SL, Wells GA, Kelly SE, Pardo Pardo J, Tugwell P, Johnston RV, Glennon V, Ejaredar M, Thomas M, Lee C, Elliott J, Mokbel A, Avery JC, Grobler L, Cyril S, Deardon R, Akl EA, Maxwell LJ, Buchbinder R, Hazlewood GS, Supported by the Cochrane Musculoskeletal Health and Pain Thematic Group

Open source

DOI: 10.1002/14651858.cd013562.pub2
Published: 2026 Jul 13
Container: The Cochrane database of systematic reviews
Publisher: Not recorded
Open access: yes

Credibility signals

limited evidence Score 45/100 under policy 1.0.0. This is a metadata assessment, not a judgment of the paper's conclusions.

Show all credibility signals

cautionDOI registered: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
cautionDOI resolves: No matching Crossref record was present in this response. Source: Crossref; license: CC0 metadata
not scoredDirectory of Open Access Journals: No matching DOAJ record was present in this response. No allow-list match; this is not evidence of low credibility. Source: DOAJ; license: CC0
not scoredMEDLINE indexed: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredOpenAlex core source: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredKnown publisher allow-list: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredROR affiliation: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredRetraction Watch retraction: No retraction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch expression of concern: No expression of concern notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch correction: No correction notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
not scoredRetraction Watch reinstatement: No reinstatement notice matched this DOI in the deployed snapshot. No matching event found; coverage may be incomplete. Source: Retraction Watch; license: CC BY 4.0
supportingOpen access status: Normalized open-access status: open. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
not scoredPublication license: Not checked or no result supplied; no credibility inference made. Source: No authority result supplied; license: Unknown
not scoredPublication version: A publication version was supplied but is not scored. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer
cautionMetadata completeness: 5 of 6 scored descriptive metadata groups are present; missing fields increase uncertainty. Source: Normalized work metadata; license: Caller-provided; provenance license not supplied to scorer

Cite this work

BibTeX

@article{allodium:10.1002/14651858.cd013562.pub2,
  title = {Disease-modifying antirheumatic drugs (DMARDs) for rheumatoid arthritis after failure of biologic or targeted synthetic therapy: a systematic review and network meta-analysis.},
  author = {Thomas J and Kamso MM and Whittle SL and Wells GA and Kelly SE and Pardo Pardo J and Tugwell P and Johnston RV and Glennon V and Ejaredar M and Thomas M and Lee C and Elliott J and Mokbel A and Avery JC and Grobler L and Cyril S and Deardon R and Akl EA and Maxwell LJ and Buchbinder R and Hazlewood GS and Supported by the Cochrane Musculoskeletal Health and Pain Thematic Group},
  year = {2026},
  journal = {The Cochrane database of systematic reviews},
  doi = {10.1002/14651858.cd013562.pub2},
  url = {https://doi.org/10.1002/14651858.cd013562.pub2}
}

RIS

TY  - JOUR
TI  - Disease-modifying antirheumatic drugs (DMARDs) for rheumatoid arthritis after failure of biologic or targeted synthetic therapy: a systematic review and network meta-analysis.
AU  - Thomas J
AU  - Kamso MM
AU  - Whittle SL
AU  - Wells GA
AU  - Kelly SE
AU  - Pardo Pardo J
AU  - Tugwell P
AU  - Johnston RV
AU  - Glennon V
AU  - Ejaredar M
AU  - Thomas M
AU  - Lee C
AU  - Elliott J
AU  - Mokbel A
AU  - Avery JC
AU  - Grobler L
AU  - Cyril S
AU  - Deardon R
AU  - Akl EA
AU  - Maxwell LJ
AU  - Buchbinder R
AU  - Hazlewood GS
AU  - Supported by the Cochrane Musculoskeletal Health and Pain Thematic Group
PY  - 2026
JO  - The Cochrane database of systematic reviews
DO  - 10.1002/14651858.cd013562.pub2
UR  - https://doi.org/10.1002/14651858.cd013562.pub2
ER  -

APA

J, T., MM, K., SL, W., GA, W., SE, K., J, P. P., P, T., RV, J., V, G., M, E., M, T., C, L., J, E., A, M., JC, A., L, G., S, C., R, D., EA, A., LJ, M., R, B., GS, H., & Group, S. B. T. C. M. H. A. P. T. (2026). Disease-modifying antirheumatic drugs (DMARDs) for rheumatoid arthritis after failure of biologic or targeted synthetic therapy: a systematic review and network meta-analysis.. The Cochrane database of systematic reviews. https://doi.org/10.1002/14651858.cd013562.pub2

Source records

pubmed · retrieved 2026-09-25T14:38:35.795Z
europe-pmc · retrieved 2026-09-25T14:38:35.803Z